PubRank

A Kamb

Author PubWeight™ 39.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996 6.43
2 Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell 1987 3.16
3 Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995 2.11
4 Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995 1.87
5 Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 1996 1.74
6 Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res 1998 1.67
7 Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain. Nucleic Acids Res 1983 1.65
8 Efficient, automatic detection of heterozygous bases during large-scale DNA sequence screening. Biotechniques 1995 1.44
9 A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. Hum Mol Genet 1994 1.34
10 Transdominant genetic analysis of a growth control pathway. Proc Natl Acad Sci U S A 1998 1.14
11 Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 1995 1.12
12 Graded mode of transcriptional induction in yeast pheromone signalling revealed by single-cell analysis. Yeast 2001 1.09
13 Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad Sci U S A 1994 0.89
14 Human potassium channel genes: Molecular cloning and functional expression. Mol Cell Neurosci 1990 0.88
15 Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst 1995 0.88
16 A review of inherited predisposition to melanoma. Semin Oncol 1996 0.87
17 Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics 1994 0.86
18 Reversible, p16-mediated cell cycle arrest as protection from chemotherapy. Cancer Res 1996 0.86
19 Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes p16 (MTS1) and p15 (MTS2). J Mol Evol 1995 0.81
20 Template selection during manipulation of complex mixtures by PCR. Biotechniques 2001 0.80
21 Creation of a stable human reporter cell line suitable for FACS-based, transdominant genetic selection. Somat Cell Mol Genet 1999 0.79
22 Genetic predisposition to melanoma. Eur J Cancer 1994 0.79
23 Cellular dialogs during development. Cell 1989 0.78
24 Expression of ion channels in cultured cells using baculovirus. Methods Enzymol 1992 0.78
25 Oligonucleotide-conjugated beads for transdominant genetic experiments. Nucleic Acids Res 2000 0.78
26 Response. Science 1994 0.78
27 Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1. Mamm Genome 1995 0.77
28 A genetic selection method for expression products that induce apoptosis in adherent mammalian cell lines. Apoptosis 2003 0.77
29 Exogenous peptide and protein expression levels using retroviral vectors in human cells. Mol Ther 2001 0.77
30 Transcriptional transactivation by selected short random peptides attached to lexA-GFP fusion proteins. BMC Mol Biol 2001 0.75
31 Cancer. Sun protection factor p53. Nature 1995 0.75
32 Enrichment during transdominant genetic experiments using a flow sorter. Cytometry 2001 0.75
33 'MHC' nomenclature. Nature 1979 0.75
34 Response. Science 1995 0.75